Valiant Organics Limited

NSE:VALIANTORG.NS

447.2 (INR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 1,679.171,767.5681,413.6082,030.9832,018.4342,714.0362,503.6582,640.722,659.6343,476.2242,883.9982,731.5622,440.9272,340.4812,065.8481,666.871,474.8781,606.3451,606.4861,638.5961,768.2522,892.4972,892.669568.929568.929433.327433.327169.896169.896325.461239.717127.22127.22244.268
Cost of Revenue 1,212.5691,322.033913.5151,347.5931,302.7451,645.2571,613.2331,733.5361,892.7352,777.8431,918.2571,847.5351,599.511,594.5631,210.672897.832728.8111,109.07962.441927.588995.5141,900.5381,900.538281.784281.784308.367308.36779.9879.98168.634160.82189.63589.635112.012
Gross Profit 466.601445.535500.093683.39715.6891,068.779890.425907.184766.899698.381965.741884.027841.417745.918855.176769.038746.067497.275644.045711.008772.739991.959992.131287.145287.145124.96124.9689.91789.917156.82778.89637.58537.585132.256
Gross Profit Ratio 0.2780.2520.3540.3360.3550.3940.3560.3440.2880.2010.3350.3240.3450.3190.4140.4610.5060.310.4010.4340.4370.3430.3430.5050.5050.2880.2880.5290.5290.4820.3290.2950.2950.541
Reseach & Development Expenses 06.220007.4670005.0220002.5230002.3650000.8730.874000.550.55000.4040.404000
General & Administrative Expenses 0000000000000000056.13500078.73278.73100000000000
Selling & Marketing Expenses 000000000000000001.1140000.830.83100000000000
SG&A 397.286123.7338.969396.009113.902397.006383.052380.131342.978392.138365.176326.707263.982333.85267.85366.37756.84257.24957.72857.76557.76579.56279.56217.56917.56917.09417.0947.2687.26810.92210.9220013.075
Other Expenses 3.81620.5823.95836.34532.12127.87514.48118.81819.153-15.89125.31416.84615.805-16.60520.06422.53916.690019.23200000000075.56600057.124
Operating Expenses 397.286581.983548.294617.414563.767625.953581.075559.949515.886169.061540.534478.935411.673196.715391.44349.681328.652157.175284.475291.781238.802362.059362.23146.58146.58147.11547.11541.74941.74975.56625.8091.1451.14557.124
Operating Income 69.315-85.162-56.244102.322151.923470.7323.832366.052251.013485.948425.207405.092429.744538.811483.799419.357417.415369.452344.693419.227483.472608.031632.369216.626216.62679.5579.5542.19942.19980.0451.395353573.485
Operating Income Ratio 0.041-0.048-0.040.050.0750.1730.1290.1390.0940.140.1470.1480.1760.230.2340.2520.2830.230.2150.2560.2730.210.2190.3810.3810.1840.1840.2480.2480.2460.2140.2750.2750.301
Total Other Income Expenses Net -45.268-166.186-41.867-38.2446.48-29.66423.047-25.06-8.1185.3412.0891.184-2.902-13.503-13.5818.5367.796-25.44710.84413.32243.3689.556-14.78221.8621.86-0.721-0.7215.1435.143-1.2212.3070.840.84-1.647
Income Before Tax 24.047-251.307-98.11164.082198.403441.036346.879340.992242.895491.288437.296406.276426.842525.308470.218427.893425.211344.005355.537432.549526.84617.587617.587238.486238.48678.82878.82847.34247.34280.0453.70235.8435.8473.485
Income Before Tax Ratio 0.014-0.142-0.0690.0320.0980.1630.1390.1290.0910.1410.1520.1490.1750.2240.2280.2570.2880.2140.2210.2640.2980.2140.2140.4190.4190.1820.1820.2790.2790.2460.2240.2820.2820.301
Income Tax Expense 28.5-49.479-19.17216.59849.085101.0186.11485.34873.683120.586114.905106.549140.534181.003124.931104.931129.03484.8685.01124.422125.775175.241175.2474.5874.5828.09228.09216.39116.39127.87318.68712.75512.75525.627
Net Income -6.195-172.191-78.93942.975124.242297.597219.691209.62154.305311.025299.359255.91266.544275.936315.827286.755246.805218.505295.933312.301397.876442.442442.442163.906163.90650.73750.73730.95230.95252.16735.01423.08523.08547.858
Net Income Ratio -0.004-0.097-0.0560.0210.0620.110.0880.0790.0580.0890.1040.0940.1090.1180.1530.1720.1670.1360.1840.1910.2250.1530.1530.2880.2880.1170.1170.1820.1820.160.1460.1810.1810.196
EPS -0.22-6.24-2.861.584.5810.968.097.725.6811.4511.029.429.8210.1612.5611.810.167.8210.5812.8614.2310.0110.0113.9813.983.143.144.254.257.172.163.173.176.57
EPS Diluted -0.22-6.24-2.861.544.4410.647.857.55.5211.1210.79.159.539.8711.2910.258.837.8110.5811.1714.2310.0110.0113.9813.983.143.144.254.257.172.163.173.176.57
EBITDA 157.142-31.82929.73191.208270.751550.46396.497437.678338.008592.428527.181490.143512.931596.713536.624493.558484.114398.643379.488473.593518.267642.134637.84222.097222.09785.02183.82344.85944.85986.72853.71137.31737.31779.848
EBITDA Ratio 0.094-0.0180.0210.0940.1340.2030.1580.1660.1270.170.1830.1790.210.2550.260.2960.3280.2480.2360.2890.2930.2220.2210.390.390.1960.1930.2640.2640.2660.2240.2930.2930.327